These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 23466486)

  • 1. Curcumin-targeting pericellular serine protease matriptase role in suppression of prostate cancer cell invasion, tumor growth, and metastasis.
    Cheng TS; Chen WC; Lin YY; Tsai CH; Liao CI; Shyu HY; Ko CJ; Tzeng SF; Huang CY; Yang PC; Hsiao PW; Lee MS
    Cancer Prev Res (Phila); 2013 May; 6(5):495-505. PubMed ID: 23466486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen-Induced TMPRSS2 Activates Matriptase and Promotes Extracellular Matrix Degradation, Prostate Cancer Cell Invasion, Tumor Growth, and Metastasis.
    Ko CJ; Huang CC; Lin HY; Juan CP; Lan SW; Shyu HY; Wu SR; Hsiao PW; Huang HP; Shun CT; Lee MS
    Cancer Res; 2015 Jul; 75(14):2949-60. PubMed ID: 26018085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of curcumin on the invasiveness of prostate cancer in vitro and in vivo.
    Hong JH; Ahn KS; Bae E; Jeon SS; Choi HY
    Prostate Cancer Prostatic Dis; 2006; 9(2):147-52. PubMed ID: 16389264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro inhibition of matriptase prevents invasive growth of cell lines of prostate and colon carcinoma.
    Förbs D; Thiel S; Stella MC; Stürzebecher A; Schweinitz A; Steinmetzer T; Stürzebecher J; Uhland K
    Int J Oncol; 2005 Oct; 27(4):1061-70. PubMed ID: 16142324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CVS-3983, a selective matriptase inhibitor, suppresses the growth of androgen independent prostate tumor xenografts.
    Galkin AV; Mullen L; Fox WD; Brown J; Duncan D; Moreno O; Madison EL; Agus DB
    Prostate; 2004 Nov; 61(3):228-35. PubMed ID: 15368474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the function of matriptase and N-acetylglucosaminyltransferase V in prostate cancer metastasis.
    Tsui KH; Chang PL; Feng TH; Chung LC; Sung HC; Juang HH
    Anticancer Res; 2008; 28(4A):1993-9. PubMed ID: 18649738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of cyclooxygenase-2-mediated matriptase activation contributes to the suppression of prostate cancer cell motility and metastasis.
    Ko CJ; Lan SW; Lu YC; Cheng TS; Lai PF; Tsai CH; Hsu TW; Lin HY; Shyu HY; Wu SR; Lin HH; Hsiao PW; Chen CH; Huang HP; Lee MS
    Oncogene; 2017 Aug; 36(32):4597-4609. PubMed ID: 28368394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression analysis of Cdc42 in lung cancer and modulation of its expression by curcumin in lung cancer cell lines.
    Chen QY; Jiao DM; Yao QH; Yan J; Song J; Chen FY; Lu GH; Zhou JY
    Int J Oncol; 2012 May; 40(5):1561-8. PubMed ID: 22266952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic upregulation of matriptase-2 reduces the aggressiveness of prostate cancer cells in vitro and in vivo and affects FAK and paxillin localisation.
    Sanders AJ; Parr C; Martin TA; Lane J; Mason MD; Jiang WG
    J Cell Physiol; 2008 Sep; 216(3):780-9. PubMed ID: 18449907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small molecule tolfenamic acid inhibits PC-3 cell proliferation and invasion in vitro, and tumor growth in orthotopic mouse model for prostate cancer.
    Sankpal UT; Abdelrahim M; Connelly SF; Lee CM; Madero-Visbal R; Colon J; Smith J; Safe S; Maliakal P; Basha R
    Prostate; 2012 Nov; 72(15):1648-58. PubMed ID: 22473873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocyte growth factor activation inhibitors (HAI-1 and HAI-2) regulate HGF-induced invasion of human breast cancer cells.
    Parr C; Jiang WG
    Int J Cancer; 2006 Sep; 119(5):1176-83. PubMed ID: 16557597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic potential of curcumin in human prostate cancer. II. Curcumin inhibits tyrosine kinase activity of epidermal growth factor receptor and depletes the protein.
    Dorai T; Gehani N; Katz A
    Mol Urol; 2000; 4(1):1-6. PubMed ID: 10851300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of matriptase-2 on prostate cancer in vitro: a possible role for β-catenin.
    Webb SL; Sanders AJ; Mason MD; Jiang WG
    Oncol Rep; 2012 Oct; 28(4):1491-7. PubMed ID: 22858929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel biomarker for staging human prostate adenocarcinoma: overexpression of matriptase with concomitant loss of its inhibitor, hepatocyte growth factor activator inhibitor-1.
    Saleem M; Adhami VM; Zhong W; Longley BJ; Lin CY; Dickson RB; Reagan-Shaw S; Jarrard DF; Mukhtar H
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):217-27. PubMed ID: 16492908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifunctional role of VIP in prostate cancer progression in a xenograft model: suppression by curcumin and COX-2 inhibitor NS-398.
    Fernández-Martínez AB; Bajo AM; Valdehita A; Isabel Arenas M; Sánchez-Chapado M; Carmena MJ; Prieto JC
    Peptides; 2009 Dec; 30(12):2357-64. PubMed ID: 19772879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A monocarbonyl analogue of curcumin, 1,5-bis(3-hydroxyphenyl)-1,4-pentadiene-3-one (Ca 37), exhibits potent growth suppressive activity and enhances the inhibitory effect of curcumin on human prostate cancer cells.
    Luo C; Li Y; Zhou B; Yang L; Li H; Feng Z; Li Y; Long J; Liu J
    Apoptosis; 2014 Mar; 19(3):542-53. PubMed ID: 24297639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin inhibits the migration and invasion of mouse hepatoma Hca-F cells through down-regulating caveolin-1 expression and epidermal growth factor receptor signaling.
    Wang S; Yu S; Shi W; Ge L; Yu X; Fan J; Zhang J
    IUBMB Life; 2011 Sep; 63(9):775-82. PubMed ID: 22362715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo.
    Dorai T; Cao YC; Dorai B; Buttyan R; Katz AE
    Prostate; 2001 Jun; 47(4):293-303. PubMed ID: 11398177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined inhibitory effects of curcumin and phenethyl isothiocyanate on the growth of human PC-3 prostate xenografts in immunodeficient mice.
    Khor TO; Keum YS; Lin W; Kim JH; Hu R; Shen G; Xu C; Gopalakrishnan A; Reddy B; Zheng X; Conney AH; Kong AN
    Cancer Res; 2006 Jan; 66(2):613-21. PubMed ID: 16423986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of EGFR signaling in human prostate cancer PC-3 cells by combination treatment with beta-phenylethyl isothiocyanate and curcumin.
    Kim JH; Xu C; Keum YS; Reddy B; Conney A; Kong AN
    Carcinogenesis; 2006 Mar; 27(3):475-82. PubMed ID: 16299382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.